Cargando…

Madagascar 2018-2019 measles outbreak response: main strategic areas

INTRODUCTION: on October 4(th), 2018, a measles outbreak was declared in Madagascar. This study describes the outbreak response in terms of coordination, case management, vaccination response and epidemiological surveillance. METHODS: data were collected using a line list and vaccination tally sheet...

Descripción completa

Detalles Bibliográficos
Autores principales: Sodjinou, Vincent Dossou, Douba, Alfred, Nimpa, Marcellin Mengouo, Masembe, Yolande Vuo, Randria, Mireille, Ndiaye, Charlotte Faty
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532848/
https://www.ncbi.nlm.nih.gov/pubmed/33062122
http://dx.doi.org/10.11604/pamj.2020.37.20.24530
_version_ 1783590009910067200
author Sodjinou, Vincent Dossou
Douba, Alfred
Nimpa, Marcellin Mengouo
Masembe, Yolande Vuo
Randria, Mireille
Ndiaye, Charlotte Faty
author_facet Sodjinou, Vincent Dossou
Douba, Alfred
Nimpa, Marcellin Mengouo
Masembe, Yolande Vuo
Randria, Mireille
Ndiaye, Charlotte Faty
author_sort Sodjinou, Vincent Dossou
collection PubMed
description INTRODUCTION: on October 4(th), 2018, a measles outbreak was declared in Madagascar. This study describes the outbreak response in terms of coordination, case management, vaccination response and epidemiological surveillance. METHODS: data were collected using a line list and vaccination tally sheet. Serum samples were collected within 30 days of rash onset for laboratory testing; confirmation was made by detection of measles immunoglobulin M antibody. RESULTS: from September 2018 to May 2019, a total of 146,277 measles cases were reported which included 1394 (1%) laboratory-confirmed cases and 144,883 (99%) epidemiological link-confirmed cases. The outbreak affected equally males (72,917 cases; 49.85%) and females (73,233 cases; 50.06%). The sex was not specified for 127 (0.09%) cases. Case fatality rate and attack rate were high among children less than 5 years. Responses interventions include effective coordination, free of charge case management, reactive vaccination, strengthened real-time surveillance, communication and community engagement and the revitalization of the routine immunization. Reactive vaccination was implemented in different phases. A total of 7,265,990 children aged from 6 months to 9 years were vaccinated. Post campaign survey coverage was 95%, 96% and 97% for phase 1, 2, 3 respectively. CONCLUSION: elimination of measles will be challenging in Madagascar because of low routine immunization coverage and the absence of a second dose of measles vaccine in the routine immunization schedule.
format Online
Article
Text
id pubmed-7532848
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The African Field Epidemiology Network
record_format MEDLINE/PubMed
spelling pubmed-75328482020-10-13 Madagascar 2018-2019 measles outbreak response: main strategic areas Sodjinou, Vincent Dossou Douba, Alfred Nimpa, Marcellin Mengouo Masembe, Yolande Vuo Randria, Mireille Ndiaye, Charlotte Faty Pan Afr Med J Research INTRODUCTION: on October 4(th), 2018, a measles outbreak was declared in Madagascar. This study describes the outbreak response in terms of coordination, case management, vaccination response and epidemiological surveillance. METHODS: data were collected using a line list and vaccination tally sheet. Serum samples were collected within 30 days of rash onset for laboratory testing; confirmation was made by detection of measles immunoglobulin M antibody. RESULTS: from September 2018 to May 2019, a total of 146,277 measles cases were reported which included 1394 (1%) laboratory-confirmed cases and 144,883 (99%) epidemiological link-confirmed cases. The outbreak affected equally males (72,917 cases; 49.85%) and females (73,233 cases; 50.06%). The sex was not specified for 127 (0.09%) cases. Case fatality rate and attack rate were high among children less than 5 years. Responses interventions include effective coordination, free of charge case management, reactive vaccination, strengthened real-time surveillance, communication and community engagement and the revitalization of the routine immunization. Reactive vaccination was implemented in different phases. A total of 7,265,990 children aged from 6 months to 9 years were vaccinated. Post campaign survey coverage was 95%, 96% and 97% for phase 1, 2, 3 respectively. CONCLUSION: elimination of measles will be challenging in Madagascar because of low routine immunization coverage and the absence of a second dose of measles vaccine in the routine immunization schedule. The African Field Epidemiology Network 2020-09-05 /pmc/articles/PMC7532848/ /pubmed/33062122 http://dx.doi.org/10.11604/pamj.2020.37.20.24530 Text en Copyright: Vincent Dossou Sodjinou et al. https://creativecommons.org/licenses/by/4.0 The Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Sodjinou, Vincent Dossou
Douba, Alfred
Nimpa, Marcellin Mengouo
Masembe, Yolande Vuo
Randria, Mireille
Ndiaye, Charlotte Faty
Madagascar 2018-2019 measles outbreak response: main strategic areas
title Madagascar 2018-2019 measles outbreak response: main strategic areas
title_full Madagascar 2018-2019 measles outbreak response: main strategic areas
title_fullStr Madagascar 2018-2019 measles outbreak response: main strategic areas
title_full_unstemmed Madagascar 2018-2019 measles outbreak response: main strategic areas
title_short Madagascar 2018-2019 measles outbreak response: main strategic areas
title_sort madagascar 2018-2019 measles outbreak response: main strategic areas
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532848/
https://www.ncbi.nlm.nih.gov/pubmed/33062122
http://dx.doi.org/10.11604/pamj.2020.37.20.24530
work_keys_str_mv AT sodjinouvincentdossou madagascar20182019measlesoutbreakresponsemainstrategicareas
AT doubaalfred madagascar20182019measlesoutbreakresponsemainstrategicareas
AT nimpamarcellinmengouo madagascar20182019measlesoutbreakresponsemainstrategicareas
AT masembeyolandevuo madagascar20182019measlesoutbreakresponsemainstrategicareas
AT randriamireille madagascar20182019measlesoutbreakresponsemainstrategicareas
AT ndiayecharlottefaty madagascar20182019measlesoutbreakresponsemainstrategicareas